openPR Logo
Press release

Cardiovascular Surgical Devices and Technologies Market Advanced Technologies & Growth Opportunities by Key Players: Abbott Cardiovascular, Abiomed, Boston Scientific Corp., C.R. Bard, St. Jude Medical, Thoratec Laboratories and More

02-22-2019 09:49 AM CET | Health & Medicine

Press release from: Allied Market Research

Cardiovascular Surgical Devices and Technologies Market

Cardiovascular Surgical Devices and Technologies Market

Cardiovascular surgery is the process performed to cure the heart tissue defects such as replacing the diseased heart valves if it is blocked, grafting or replacement of heart tissues in case of damage. There are two major types of heart surgeries performed, namely closed and open types of surgeries.

Key companies included in company profiles are Abbott Cardiovascular, Abiomed, Inc., Boston Scientific Corp., C.R. Bard, INC., St. Jude Medical, Thoratec Laboratories, Transmedics, Inc., Cook Medical, Cordis Corp., and Angiodynamics, Inc.

Get Sample PDF Brochure of Cardiovascular Surgical Devices and Technologies Market Study at: https://www.alliedmarketresearch.com/request-toc-and-sample/194

The global surgical device market is the parent market for cardiovascular devices, which was valued at $240 billion in 2013. Increase in incidence for heart related problems are mainly due to changes in life style. This life style changes has increased the rate of heart surgeries. The U.S. is the leading market for cardiovascular surgical devices due to increase in aging population that is suffering from cardiovascular problems.

The growth of cardiovascular surgical devices market was hampered by efficient alternative technologies such as percutaneous coronary intervention (PCI) techniques and other minimal invasive techniques (Ablation techniques); moreover, shortage of skilled surgeons and high cost of surgical procedures are hindering the growth of cardiovascular surgical device market in developing countries. Lower success rate of heart related surgeries in minimal invasive techniques is reducing the growth of cardiovascular surgical device market in developing economies.

The global cardiovascular surgical device market is dominated by established companies due to high cost of investment require for breaking surgical device market. Cardiovascular surgical device market is facing challenges from alternative technologies that are developing at a faster rate as compared to surgical technologies. However, lower success rate of these alternative technologies has reduced the growth in cardiovascular surgical market in developing countries.

This report provides market intelligence of revenue and growth rate during analysis period. The report also provides key developmental strategies adopted by top companies engaged in surgical device manufacturing. The report provides market intelligence on current trends and future transition of surgical devices.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/194

Key Benefits

• The market estimation made in this report by collecting primary information from respective companies involved in manufacturing of medical devices. Analyzing secondary information provides competitive analysis about trends during 2013-2020
• The report analyzes the key developmental strategies adopted by top ranking companies and change in trends for this adoption
• Practical evaluation of key market drivers and restraints
• This report provides emphasis on key factors impacting the growth of portable medical device market
• Patent analysis for different geographic regions is dealt with key clinical trials and applications

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiovascular Surgical Devices and Technologies Market Advanced Technologies & Growth Opportunities by Key Players: Abbott Cardiovascular, Abiomed, Boston Scientific Corp., C.R. Bard, St. Jude Medical, Thoratec Laboratories and More here

News-ID: 1609507 • Views:

More Releases from Allied Market Research

Retail Analytics Market Expected to Reach USD 58.4 Billion by 2032 at 22.6% CAGR, Key Factors behind Market's Exponential Growth
Retail Analytics Market Expected to Reach USD 58.4 Billion by 2032 at 22.6% CAGR …
According to the report published by Allied Market Research, The Retail Analytics Market Expected to Reach USD 58.4 Billion by 2032 at 22.6% CAGR, Key Factors behind Market's Exponential Growth. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers valuable able guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining
Pain Management Drugs Market to Reach USD 91.64 Billion, Globally, by 2027 at 3.8% CAGR: Allied Market Research
Pain Management Drugs Market to Reach USD 91.64 Billion, Globally, by 2027 at 3. …
According to the report, the global Pain Management Drugs Market size was estimated at USD 71.43 billion in 2019, and is anticipated to hit USD 91.64 billion by 2027, registering a CAGR of 3.8% from 2020 to 2027. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-for-customization/404?reqfor=covid 𝐃𝐫𝐢𝐯𝐞𝐫𝐬, 𝐫𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬, 𝐚𝐧𝐝 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬- Increase in prevalence of chronic diseases, favorable regulatory scenario, and surge in the number of geriatric population drive the growth of the global
Organic Cheese Market is Set To Fly High in Years to Come | $16.3 Billion by 2032
Organic Cheese Market is Set To Fly High in Years to Come | $16.3 Billion by 203 …
According to a new report published by Allied Market Research, titled, "Organic Cheese Market," The organic cheese market size was valued at $7.3 billion in 2022, and is estimated to reach $16.3 billion by 2032, growing at a CAGR of 8.5% from 2023 to 2032. Request Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A15492 Organic cheese contains all the goodness from regular cheese, including the high levels of protein and calcium. However, research has
Optical Preclinical Imaging Market Expected to Reach USD 859.70 Million by 2030 | CAGR of 5.2% - AMR
Optical Preclinical Imaging Market Expected to Reach USD 859.70 Million by 2030 …
Optical imaging device serves as a standard tool in preclinical drug discovery and development. This modality offers a virtual window inside the animals, thus facilitating the tracking of biological activities at the molecular level. This method is simple to use, offers fast throughput, is reasonably priced with outstanding sensitivity, and does not emit radiations. Noninvasive in vivo imaging methods have elevated the use of animal models in preclinical drug discovery

All 5 Releases


More Releases for Cardiovascular

Increasing Prevalence of Cardiovascular Diseases to Augment the Cardiovascular I …
Cardiovascular information system offers on-time access to cardiovascular electronic medical records in reports, images, and waveforms, and allows easy report generation and distribution. Cardiovascular information system is extensively used in electrocardiography (ECG) data management, echocardiography, catheterization, and vascular solutions. Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/20 Cardiovascular information system is used to store, archive, and share healthcare information. It is a unique software solution that helps improve the clinical and financial
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Mexico Cardiovascular Devices Market Outlook to 2025 Cardiac Assist Devices, Car …
Orbisresearch.com has announced the addition of Mexico Cardiovascular Devices Market. The report focuses on global major leading industry players with information such as company profiles, product picture and specification. Mexico Cardiovascular Devices Market Outlook to 2025, provides key market data on the Mexico Cardiovascular Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Cardiac Assist Devices, Cardiac Rhythm
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Increasing Cardiovascular Surgeries Leads To Higher Market Value For Cardiovascu …
When a coronary artery is narrowed by the accumulation of fatty acids, also known as plaque, the blood flow to heart is reduced which result in the chest pain and if the blockage increases the blood flow to the heart is further reduced and might lead to cardiac arrest. To reduce the chances of heart attack, a tiny wire mesh tube is inserted in the artery with a balloon catheter,
Cardiovascular Monitoring and Diagnostic Devices Market to be Driven with the Ri …
The global market for cardiovascular monitoring and diagnostic devices is expected to expand at a healthy CAGR of 6.4% over the period between 2016 and 2024, rising from a valuation of US$1.8 bn in 2015 to US$3.1 bn by 2024. The segment of ECG systems contributed the largest share to the market’s overall revenues in 2015, accounting for nearly US$878 mn in 2015. However, the segment of implantable loop recorder